Systemic Exposure to Hydroxychloroquine and its relationship with outcome in severely ill COVID‐19 patients in New York City

This study in severely ill patients was not able to find any relationship between systemic exposure to HCQ and DHCQ and clinical outcome at a routine dose regimen and adds to the growing body of evidence that oral HCQ does not alter the course of disease in COVID-19 patients.